MELD score is an important predictor of pretransplantation mortality in HIV-infected liver transplant candidates.

Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA.
Gastroenterology (Impact Factor: 12.82). 09/2009; 138(1):159-64. DOI: 10.1053/j.gastro.2009.09.053
Source: PubMed

ABSTRACT Human immunodeficiency virus (HIV) infection accelerates liver disease progression in patients with hepatitis C virus (HCV) and could shorten survival of those awaiting liver transplants. The Model for End-Stage Liver Disease (MELD) score predicts mortality in HIV-negative transplant candidates, but its reliability has not been established in HIV-positive candidates.
We evaluated predictors of pretransplantation mortality in HIV-positive liver transplant candidates enrolled in the Solid Organ Transplantation in HIV: Multi-Site Study (HIVTR) matched 1:5 by age, sex, race, and HCV infection with HIV-negative controls from the United Network for Organ Sharing.
Of 167 HIVTR candidates, 24 died (14.4%); this mortality rate was similar to that of controls (88/792, 11.1%, P = .30) with no significant difference in causes of mortality. A significantly lower proportion of HIVTR candidates (34.7%) underwent liver transplantation, compared with controls (47.6%, P = .003). In the combined cohort, baseline MELD score predicted pretransplantation mortality (hazard ratio [HR], 1.27; P < .0001), whereas HIV infection did not (HR, 1.69; P = .20). After controlling for pretransplantation CD4(+) cell count and HIV RNA levels, the only significant predictor of mortality in the HIV-infected subjects was pretransplantation MELD score (HR, 1.2; P < .0001).
Pretransplantation mortality characteristics are similar between HIV-positive and HIV-negative candidates. Although lower CD4(+) cell counts and detectable levels of HIV RNA might be associated with a higher rate of pretransplantation mortality, baseline MELD score was the only significant independent predictor of pretransplantation mortality in HIV-infected liver transplant candidates.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Liver disease is one of the most frequent causes of non AIDS related deaths in HIV patients and transplantation has become a therapeutic option. In spite of this progress, no liver transplantation has ever been recorded for the patients of the Brussels Saint-Pierre HIV Cohort. The aim of this study is to identify the barriers to liver transplantation in HIV patients that arise in our practice. All patients enrolled in the Brussels Saint-Pierre HIV Cohort presenting a theoretical indication for liver transplantation, as recommended by the AASLD, between 01/01/2002 and 01/07/2010 were considered. The reasons for not retaining these patients as candidates for liver transplantation were classified as HIV or non-HIV related. Nineteen patients were identified. All patients presented an HBV and/or HCV co-infection. Indication for liver transplantation was based on first severe complication of cirrhosis for 15 patients, hepatocellular carcinoma fulfilling the Milan criteria for 2 and chronic liver failure for 2 others. Three patients could have been transplantation candidates but only one was enlisted and died prior to transplantation whilst alternative treatments were chosen for the remaining two. Among the non candidates, 5 couldn't be enlisted for HIV-related reasons, 3 for non HIV related reasons and 8 on multifactorial grounds; non adherence to treatment, alcohol abuse, psychiatric disease and hepatotoxicities playing key roles. Eleven patients died, all within 12 months of their first major complication of cirrhosis. The undeniable medical progress that liver transplantation represents for HIV-infected individuals is, in practise, limited; only a minority of patients with an indication of liver transplant will fulfill the necessary criteria for enlistment. General awareness of this issue and early referral are essential to optimize pre-transplant management and increase the number of HIV patients developing ESLD that will be able to benefit from this cure.
    Acta clinica Belgica 09/2013; 68(5):349-55. DOI:10.2143/ACB.3249 · 0.59 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Case-control sampling can be an efficient and cost-saving study design, wherein subjects are selected into the study based on the outcome of interest. It was established long ago that proportional hazards regression can be applied to case-control data. However, each of the various estimation techniques available assumes that failure times are independently censored. Since independent censoring is often violated in observational studies, we propose methods for Cox regression analysis of survival data obtained through case-control sampling, but subject to dependent censoring. The proposed methods are based on weighted estimating equations, with separate inverse weights used to account for the case-control sampling and to correct for dependent censoring. The proposed estimators are shown to be consistent and asymptotically normal, and consistent estimators of the asymptotic covariance matrices are derived. Finite-sample properties of the proposed estimators are examined through simulation studies. The methods are illustrated through an analysis of pre-transplant mortality among end-stage liver disease patients obtained from a national organ failure registry. (C) 2014 Statistical Society of Canada
    Canadian Journal of Statistics 06/2014; 42(3). DOI:10.1002/cjs.11218 · 0.59 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The demand for definitive management of end-stage organ disease in HIV-infected Canadians is growing. Until recently, despite international evidence of good clinical outcomes, HIV-infected Canadians with end-stage liver disease were ineligible for transplantation, except in British Columbia (BC), where the liver transplant program of BC Transplant has accepted these patients for referral, assessment, listing and provision of liver allograft. There is a need to evaluate the experience in BC to determine the issues surrounding liver transplantation in HIV-infected patients.

Full-text (2 Sources)

Available from
May 17, 2014